GSK’s Andrew Witty: Addressing Neglected Tropical Diseases and Global Health Issues — Open Labs, Open Minds (B)
(4 pages of text)
This case is a supplement to GSK’s Andrew Witty (A).
The (A) case can be used as a standalone case or in conjunction with the (B) case. Both cases focus on the charge against GSK that it values profits over people, especially with regard to less economically developed nations. After engaging with the case materials, students should be able to:
Demonstrate an understanding of the complexity of making decisions in emotionally fraught international contexts.
Argue for or against GSK’s patent pool program, and describe the differences between the traditional pharmaceutical business model and the patent pool business model.
Show competence in stakeholder mapping and demonstrate a deep understanding of stakeholders’ points of view.
United Kingdom;Global, Large, 2010
$2.55 CAD / $2.55 USD Printed Copy
$2.25 CAD / $2.25 USD Permissions
$2.25 CAD / $2.25 USD Digital Download